Search

Background and Aim: The study aims to evaluate the feasibility of body mass index (BMI)‐based individualized small bowel preparation for computed tomography enterography (CTE). Methods: In this prospective randomized controlled study, patients undergoing CTE were randomly assigned to the individualized group or standardized group. Those in individualized group were given different volumes of mannitol solution based on BMI (1000 mL for patients with BMI < 18.5 kg/m2, 1500 mL for patients with 18.5 kg/m2 ≤ BMI < 25 kg/m2 and 2000 mL for patients with BMI ≥ 25 kg/m2) while patients in the standardized group were all asked to consume 1500‐mL mannitol solution. CTE images were reviewed by two experienced radiologists blindly. Each segment of the small bowel was assessed for small bowel image quality and disease detection rates. Patients were invited to record a diary regarding adverse events and acceptance. Results: A total of 203 patients were enrolled and randomly divided into two groups. For patients with BMI < 18.5 kg/m2, 1000‐mL mannitol solution permitted a significantly lower rate of flatulence (P = 0.045) and defecating frequency (P = 0.011) as well as higher acceptance score (P = 0.015), but did not affect bowel image quality and diseases detection compared with conventional dosage. For patients with BMI ≥ 25 kg/m2, 2000‐mL mannitol solution provided better overall image quality (P = 0.033) but comparable rates of adverse events and patients' acceptance compared with conventional dosage. Conclusions: Individualized bowel preparation could achieve both satisfactory image quality and patients' acceptance thus might be an acceptable alternative in CTE. [ABSTRACT FROM AUTHOR]

Results of the QCICD/6-311 + + G(3df,3pd) ab initio calculations on the ground state of Ar[sub 2]H[sup +] are presented. With accurate method and basis sets, the potential energy surface for the ground state was scanned with more than 7000 points, and an analytic global potential energy surface was constructed based on these points. The properties such as the potential minima, the transition state, and the dissociating paths of [Ar-H-Ar][sup +] were discussed. The influence of the three-body interaction in this system was also investigated, and it is found that a potential based on the two-body additive interaction is not good to represent the Ar[sub 2]H[sup +] system. [ABSTRACT FROM AUTHOR]

Objectives: To determine the impact of long-term use of antibiotics and ultraviolet radiation on the resistance of Acinetobacter baumannii to tigecycline and the viability of tigecycline-resistant Acinetobacter baumannii ., Methods: Three strains of tigecycline sensitive Acinetobacter baumannii were selected. Tigecycline resistance was induced through multi-step method or by ultraviolet radiation. Two strains of tigecycline resistant Acinetobacter baumannii were repeatedly passaged on blank MHA plates, for the purpose of determination of minimum inhibitory concentrations (MICs) of tigecycline using broth microdilution method. The tigecycline sensitive (b38) and homologous resistant Acinetobacter baumannii (b38!d) were cultured separately and conjointly to evaluate its fitness costs of tigecycline resistance., Results: Tigecycline resistant strains were successfully induced using multi-step method. Ultraviolet radiation did not change the sensitivity of the three strains to tigecycline, but elevated the MICs of tigecycline. The MICs of tigecycline did not change over 40 generations. It took much more time for the resistant strains to reach logarithmic growth phase and plateau phase compared with the tigecycline sensitive strains. With repeated passage, the tigecycline resistant strains decreased rapidly, even vanished in conjointly culture., Conclusion: Acinetobacter baumannii can acquire tigecycline resistance. The resistance may have genetic stability. The resistant strains have less adaptability than the sensitive strains.

Objective: To study the prevalence of 16S rRNA methylase genes in extended-spectrum-lactamascs (ESBLs)-producing Enterobacteriacea, and the correlations of 16S rRNA methylase genes with anminoglycoside resistnace., Methods: Seventy-four ESBLs-producing Enterobacteriacea stains were isolated from urinary tract infections. Minimal inhibitory concentrations (MICs) of 5 aminoglycosides against the ESBLs-producing Enterobacteriacea were detected by two-fold agar dilution method. PCR amplification and DNA sequencing were used for screening and identifying 16S rRNA methylase genes. The clonality of 16S rRNA methylase gene positive ESBLs-producing Enterobacteriaceae was assessed by multilocus sequence typing (MLST)., Results: The bacterial resistant rates to gentamycin, netilmicin, tobramycin,amikacin and isepamicin were 93.4%, 18.4%, 13.2%, 5.3% and 5.3%, respectively. Tweenty-two out of 74 clinical isolates were 16S rRNA methylase genes positive (29.7%), including 18 armA gene and 7 rmtB gene, and 3 strains with both genes. The resistant rates of those 22 strains to gentamycin , netilmicin, tobramycin, amikacin and isepamicin were 100%, 100%, 59.1%, 18.2% and 18.2%, respectively. Among 19 E. coli isolates, seven sequence types (STs) were identified, named as ST117 (12 strains), ST2003 (2 strains), ST3843 (1 strain), ST915 (1 strain), ST844 (1 strain), ST2581 (1 strain) and ST2922 (1 strain). MLST showed that 3 K. pneumoniae isolates were nonclonal., Conclusion: 16S rRNA methylase genes were widely distributed in urinary ESBLs-producing Enterobacteriacea, showing obvious relationship with the resistance to aminoglycosides. The therapy of Amikacin or Isepamicin may be considered in UTIs with 16S rRNA gene positive ESBLs-producing Enterobacteriacea.